Trending Stocks : AT&T (NYSE:T), Sprint Corporation (NYSE:S), Avanir Pharmaceuticals (NASDAQ:AVNR), Booz Allen Hamilton (NYSE:BAH), Syngenta (NYSE:SYT)

Zacks reissued their outperform rating on shares of AT&T (NYSE:T) in a research report released on Wednesday morning. Zacks currently has a $12.00 price objective on the stock. AT&T, Inc. (NYSE:T)’s stock on 31 July traded at beginning with a price of $36.05 and when day-trade ended the stock finally fell -2.12% to end at $35.59. AT&T, Inc. (NYSE:T)’s showed weekly performance of 0.25%.

Sprint Corporation (NYSE:S) fell as French telecommunications company Iliad announced a bid to buy T-Mobile (TMUS_).  Iliad has offered $15 billion in cash for 56.6% of T-Mobile, or $33 a share, according to The Wall Street Journal. Sprint and T-Mobile had agreed on broad strokes of a merger that would value T-Mobile at $30 billion and would combine the third-largest and fourth-largest U.S. wireless carriers, respectively.  Sprint Corporation (NYSE:S) on Thursday closed at $7.35. Stock institutional ownership is 18.20% while insider ownership includes 0.30%. Sprint Corporation (NYSE:S) distance from 50-day simple moving average (SMA50) is -13.98%.

On July 28, 2014, Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) will report financial results for the quarter ended June 30, 2014 after market close on Tuesday, August 5, 2014. The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day.  Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR)’s shares on Thursday traded in the range of 5.21 – 5.44and ended up on $5.21. Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) distance from 200-day simple moving average (SMA200) is 21.01%. AVNR’s sales growth for past 5 years was 60.90% and its EPS growth for past 5 years was -14.40%.

Investment analysts at JPMorgan Chase & Co. hoisted their target price on shares of Booz Allen Hamilton Holding Corp. (NYSE:BAH) from $25.00 to $26.00 in a note issued to investors on Thursday. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.’s price target suggests a potential upside of 15.66% from the stock’s previous close. Booz Allen Hamilton Holding Corporation (NYSE:BAH)’s stock on 31 July fell -1.07% to the closing price of $22.24. Its fifty two weeks range is $16.61 – 25.32. The total market capitalization recorded $3.222B. Booz Allen Hamilton Holding Corporation (NYSE:BAH) monthly performance is 3.11%.

Syngenta AG (NYSE:SYT) recently reported financial results for the first half of 2014 (ended Jun 30, 2014). Earnings per share, excluding restructuring and impairment charges, came in at $15.60 (or $3.12 per ADR), down 2.0% from $15.92 reported in the first half of 2013. In the reported half year, sales climbed 1% year over year to $8,508 million year over year. At Constant Exchange Rate (:CER), revenues increased 4% backed by price and volume gains. Syngenta AG (NYSE:SYT) on Thursday closed at $70.94. Stock institutional ownership is 4.10%. Syngenta AG (NYSE:SYT) distance from 50-day simple moving average (SMA50) is -5.41%.